Stealthy Viral Vectors May Improve Delivery of Gene Therapies for Hemophilia (2 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Stealthy Viral Vectors May Improve Delivery of Gene Therapies for Hemophilia (2 of 2)

Caption

The new lentiviral vectors (LVs, black dots) harbor a protein named CD47 that protects them from the immune system. This material relates to a paper that appeared in the May 22, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by M. Milani at IRCCS San Raffaele Scientific Institute in Milan, Italy; and colleagues was titled, "Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates."

Credit

M. Milani <i>et al., Science Translational Medicine</i> (2019)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.